HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation
Journal of Pathology and Translational Medicine. 2020;54(1):34-44 
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
Breast Cancer Research. 2007;9(5):
Recommendation to Revise the AJCC/UICC Breast Cancer Staging System for Inclusion of Proven Prognostic Factors: ER/PR Receptor Status and HER2 neu
Clinical Breast Cancer. 2011;11(5):346-347
Predicting HER2 status of breast cancer from basic pathology features: HER2 status of 1500 breast cancers determined by immunohistochemistry and flourescence In situ hybridisation with pathology correlation
European Journal of Cancer. 2002;38(11):S52
HER2 Testing in the Era of Changing Guidelines
Her2-Positive Breast Cancer. 2019;13-39
New Insights to Reshape the Management of Patients with Metastatic Breast Cancer - Focus on Overcoming Challenges in HER2 Status Interpretation
The Open Biomarkers Journal. 2020;10(1):38-46
P240 Impact of modified 2013 ASCO/CAP guidelines on HER2 testing in breast cancer
The Breast. 2015;24:S108
Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines
Human Pathology. 2005;36(3):250-261
PO27 HER2 and steroid receptor status in pregnancy-associated breast cancer
The Breast. 2012;21:S10
How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?
Breast Cancer Research. 2013;15(1):